C.-M. Lee

A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy

K.-C. Chang, Chien‐Hui Hung, S.-N. Lu et al. · Journal of Antimicrobial Chemotherapy · 2012 · 101 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Prevalence and Clinical Implications of Hepatitis B Virus Genotypes in Southern Taiwan

C.-M. Lee, Chia‐Hsiang Chen, Sheng‐Nan Lu et al. · Scandinavian Journal of Gastroenterology · 2003 · 68 citations

Medicine, Genetics, Molecular Genetics +17

Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients

Chia‐Hsiang Chen, Chien‐Hui Hung, J.-H. Wang et al. · Clinical Microbiology and Infection · 2017 · 65 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience

Ming‐Chao Tsai, Chia‐Hsiang Chen, Po‐Lin Tseng et al. · Clinical Microbiology and Infection · 2015 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +16

Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study

I.-T. Wu, T.-H. Hu, C.-H. Hung et al. · Clinical Microbiology and Infection · 2017 · 43 citations

Pharmacy, Pharmacology, Pharmacotherapy +16